Company: SXTPW
Filing Date: 2025-03-27
Form Type: S-1/A
Source: 0001013762-25-003353
Chunk: 173

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: S-1/A
Chunk 173
---
 above address and in December 2024, we renewed our lease for an additional one-year term that expires March 31, 2026. 107 Legal Proceedings From time to time, we may become involved in various claims and legal proceedings. We are not currently a party to any legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors. History 60 Degrees Pharmaceuticals, Inc. is a Delaware corporation that was incorporated on June 1, 2022. On June 1, 2022, 60 Degrees Pharmaceuticals, LLC, a District of Columbia limited liability company (“60P LLC”), entered into the Agreement and Plan of Merger with 60 Degrees Pharmaceuticals, Inc., pursuant to which 60P LLC merged into 60 Degrees Pharmaceuticals, Inc. The value of each outstanding member’s membership interest in 60P LLC was correspondingly converted into common stock of 60 Degrees Pharmaceuticals, Inc., par value $0.0001 per share, with a cost-basis equal to $300.00 per share. We also operate one subsidiary. A summary of our majority-owned subsidiary is below. We own 97% equity in 60P Australia Pty Ltd, a Sydney-Australia based subsidiary (“60P Australia”). 60P Australia holds sub-licensing rights for several ex-U.S. territories for our product. 60P Australia previously solely owned a Singaporean subsidiary company, 60P Singapore Pte. Ltd., which dissolved at our election in the second quarter of 2022. MANAGEMENT The following table sets forth the name, age and position of each of our executive officers, directors and director nominees as of March 27, 2025.

| Name           
 Geoffrey Dow   |     | Age 
  51 |     | Position                           
 Chief Executive Officer, President 
 and Director                       |     | Director      
 Since         
 June 1, 2022  |
|:---------------|:----|----:|:----|:-----------------------------------|:----|:--------------|
| Tyrone Miller  |     |  50 |     | Chief Financial Officer            |     |               |
| Kristen Landon |     |  58 |     | Chief Commercial Officer           |     |               |
| Charles Allen  |     |  49 |     | Director                           |     | July 11,